» Articles » PMID: 22189537

Small Randomized Trial Among Low-birth-weight Children Receiving Bacillus Calmette-Guérin Vaccination at First Health Center Contact

Overview
Specialty Pediatrics
Date 2011 Dec 23
PMID 22189537
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

A total of 105 low-birth-weight children presenting for first vaccination were randomized to receive bacillus Calmette-Guérin (BCG) immediately or later (current practice). The mortality rate ratio for BCG was 0.17 (95% CI = 0.02-1.35) within 3 days of enrollment, 0.28 (0.06-1.37) in the first month, and 0.27 (0.07-0.98) after 2 months of age. The mortality rate ratio was 0.41 (0.14-1.18) (P = 0.098) in infancy. Administration of BCG vaccine at first contact may contribute to lower mortality.

Citing Articles

Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette-Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases.

Jurczak M, Druszczynska M Pathogens. 2025; 14(2).

PMID: 40005571 PMC: 11857995. DOI: 10.3390/pathogens14020196.


The spleen assumes a major role in blood glucose regulation in type 1 diabetes patients treated with BCG.

Dias H, Fu J, Luck T, Wolfe G, Hostetter E, Ng N Sci Rep. 2024; 14(1):17611.

PMID: 39080423 PMC: 11289084. DOI: 10.1038/s41598-024-67905-x.


Editorial: Vaccine-induced innate immunity and its role in viral infections.

Rahman M, Gelanew T, Barman S, Nainu F Front Immunol. 2024; 15:1440061.

PMID: 39055719 PMC: 11270504. DOI: 10.3389/fimmu.2024.1440061.


Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseases.

Kuhtreiber W, Hostetter E, Wolfe G, Vaishnaw M, Goldstein R, Bulczynski E iScience. 2024; 27(6):109881.

PMID: 39055605 PMC: 11270028. DOI: 10.1016/j.isci.2024.109881.


Rationale for Randomized Clinical Trials Investigating the Potential of BCG Vaccination in Preventing COVID-19 Infection.

Noval Rivas M, Rosser C, Arditi M Bladder Cancer. 2024; 7(2):121-131.

PMID: 38994533 PMC: 11181712. DOI: 10.3233/BLC-201529.